Athula Herath
Granta Park
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sputum biomarkers during acute severe asthma attacks in children-a case-control study.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: June 30, 2021
Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum.
Journal: BMC pulmonary medicine
Published: May 22, 2018
Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.
Journal: The Journal of allergy and clinical immunology
Published: July 21, 2017
EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
Journal: The Journal of allergy and clinical immunology
Published: March 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.
Journal: The Journal of allergy and clinical immunology
Published: December 02, 2016
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2016
Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis.
Journal: The Journal of allergy and clinical immunology
Published: July 06, 2016
Sputum Inflammatory Mediators Are Increased in Aspergillus fumigatus Culture-Positive Asthmatics.
Journal: Allergy, asthma & immunology research
Published: April 27, 2016
Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.
Journal: Chemistry & biology
Published: June 01, 2015
A panel of biomarkers for disease severity in atopic dermatitis.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 21, 2015
Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.
Journal: American journal of respiratory cell and molecular biology
Published: December 12, 2013
Last Updated: 09/26/2026